We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+12.95%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$495M
AUM Growth
+$50.8M
Cap. Flow
+$15.9M
Cap. Flow %
3.21%
Top 10 Hldgs %
39.31%
Holding
95
New
17
Increased
22
Reduced
27
Closed
14

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$18.2M
2
AMT icon
American Tower
AMT
+$17.9M
3
CSGP icon
CoStar Group
CSGP
+$15.9M
4
BAX icon
Baxter International
BAX
+$14.6M
5
RGLD icon
Royal Gold
RGLD
+$12.4M

Sector Composition

Rank Sector Weight
1 Technology 29.48%
2 Healthcare 20.26%
3 Financials 15.17%
4 Industrials 7.35%
5 Communication Services 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATO icon
51
Atmos Energy
ATO
$29.9B
$1.83M 0.37%
16,400
-200
-1% -$21.9K
HSIC icon
52
Henry Schein
HSIC
$9.74B
$1.66M 0.34%
24,910
GIS icon
53
General Mills
GIS
$19.2B
$1.65M 0.33%
30,750
-194,400
-86% -$10.2M
NKE icon
54
Nike
NKE
$61.9B
$1.35M 0.27%
13,300
BFAM icon
55
Bright Horizons
BFAM
$3.99B
$1.34M 0.27%
8,900
-200
-2% -$30K
NBIX icon
56
Neurocrine Biosciences
NBIX
$17.7B
$1.29M 0.26%
12,050
-300
-2% -$31.4K
TT icon
57
Trane Technologies
TT
$106B
$1.28M 0.26%
9,650
-32,900
-77% -$4.17M
MAS icon
58
Masco
MAS
$16B
$1.27M 0.26%
26,400
+200
+0.8% +$9.09K
RGA icon
59
Reinsurance Group of America
RGA
$15.7B
$975K 0.2%
5,978
+78
+1% +$12.6K
GILD icon
60
Gilead Sciences
GILD
$161B
$928K 0.19%
14,290
-1,000
-7% -$65.1K
STE icon
61
Steris
STE
$20.9B
$846K 0.17%
5,550
-39,200
-88% -$5.75M
IART icon
62
Integra LifeSciences
IART
$1.54B
$845K 0.17%
14,498
MGA icon
63
Magna International
MGA
$17.9B
$765K 0.15%
13,950
-100
-0.7% -$5.42K
SHW icon
64
Sherwin-Williams
SHW
$78.3B
$731K 0.15%
3,759
+9
+0.2% +$1.72K
ALXN
65
DELISTED
Alexion Pharmaceuticals
ALXN
$708K 0.14%
6,550
-700
-10% -$74.9K
CTAS icon
66
Cintas
CTAS
$82.4B
$646K 0.13%
9,600
CI icon
67
Cigna
CI
$76.6B
$560K 0.11%
2,739
+9
+0.3% +$1.65K
ECL icon
68
Ecolab
ECL
$75.6B
$531K 0.11%
2,750
CMD
69
DELISTED
Cantel Medical Corporation
CMD
$475K 0.1%
6,700
QRVO icon
70
Qorvo
QRVO
$7.63B
$440K 0.09%
3,783
ABT icon
71
Abbott
ABT
$180B
$434K 0.09%
5,000
CTSH icon
72
Cognizant
CTSH
$21.5B
$397K 0.08%
6,408
WASH icon
73
Washington Trust Bancorp
WASH
$732M
$391K 0.08%
7,264
BLD
74
DELISTED
TopBuild
BLD
$332K 0.07%
3,225
+55
+2% +$5.72K
SRCL
75
DELISTED
Stericycle Inc
SRCL
$329K 0.07%
5,151
+467
+10% +$27.6K

Similar funds

De Burlo Group's Q4 2019 Portfolio in Review

As of Q4 2019, De Burlo Group held 95 positions worth $495M, up 11% from $444M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

De Burlo Group deployed $15.9M of net new capital in Q4 2019, opening 17 new positions and adding to 22 existing holdings. Its largest new stake was Alphabet (Google) Class A: 277,000 shares worth $18.6M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Crown Castle, an estimated $18.2M trimmed.

  • De Burlo Group's largest Q4 2019 buy was Alphabet (Google) Class A: 277,000 shares worth $18.6M.
  • De Burlo Group added most to Adobe in Q4 2019, an estimated $11.8M increase.
  • De Burlo Group's biggest Q4 2019 reduction was Crown Castle, cutting an estimated $18.2M.
  • De Burlo Group fully exited CoStar Group in Q4 2019, selling an estimated $15.9M.
  • De Burlo Group's ten largest holdings make up 39% of its $495M portfolio in Q4 2019.
  • De Burlo Group opened 17 new positions and closed 14 in Q4 2019.
  • De Burlo Group's portfolio value rose 11% quarter-over-quarter to $495M.

Based on De Burlo Group's 13F filing for Q4 2019, filed 6 Feb 2020.